Two statistical models for forecasting from very short time series have been applied to serial data from 162 participants in a health monitoring program. One model assumes stationary ("homeostatic") variability over time with statistically independent observations: the other model presumes nonstationary ("random walk") variation with a high degree of autocorrelation between observations. The data consist of results from 14 biochemical and seven hematological tests in blood collected on several successive weeks during each of four or more annual examinations of the subjects. Based on the average week-to-week variation in a given individual during the first three sampling periods, forecast ranges for the mean of every analyte measured during the fourth period in that individual were calculated from the two models. The random-walk model was better at detecting trends (at the 5% level of significance) during the first four sampling periods, with an average sensitivity of 56%, close to that predicted from theory. The stationary model was more adept at detecting a sudden nonrandorn change from the past record. When both models were used together, about 63% of the highest decile of nontrend changes were detected. We present tabulations of the magnitudes of observed trends and of the larger non-trend changes so that the probable clinical usefulness of detecting such changes may be assessed.
On the Use of Statistical Models of Within-Person Variation in Long-Term Studies of Healthy Individuals
Eugene K. Harris,1 Bruce K. Cooil,3 George Shakarji,2 and George Z. Williams3
Two statistical models for forecasting from very short time series have been applied to serial data from 162 participants in a health monitoring program. One model assumes stationary ("homeostatic") variability over time with statistically independent observations: the other model presumes nonstationary ("random walk") variation with a high degree of autocorrelation between observations. The data consist of results from 14 biochemical and seven hematological tests in blood collected on several successive weeks during each of four or more annual examinations of the subjects. Based on the average week-to-week variation in a given individual during the first three sampling periods, forecast ranges for the mean of every analyte measured during the fourth period in that individual were calculated from the two models. The random-walk model was better at detecting trends (at the 5% level of significance) during the first four sampling periods, with an average sensitivity of 56%, close to that predicted from theory. The stationary model was more adept at detecting a sudden nonrandorn change from the past record. When both models were used together, about 63% of the highest decile of nontrend changes were detected. We present tabulations of the magnitudes of observed trends and of the larger non-trend changes so that the probable clinical usefulness of detecting such changes may be assessed.
Additional Keyphrases: detection and evaluation of trends, unusual results
statistics inter-and intra-personal variation . health monitoring .
analytical error
In a recent paper (1) , three statistical models of intraindividual variation in blood constituents were reviewed, and two were suggested as practical methods for detecting nonrandom changes.
One model, based on a stationary, strictly homeostatic kind of variation, prescribes that a current observation be compared with the mean of all previous results. This is probably the most appropriate scheme for following changes in closely controlled variables. For less tightly controlled variables, a nonstationary "random-walk" model was proposed. By this model, a current observation is compared with an exponentially smoothed average of previous observations.4 The smoothed average gives greatest weight to the observation immediately preceding the current observation. The joint use of both models ss recommended to determine ranges for evaluating future changes. A stepwise algorithm for calculating these ranges appeared in 2.
In the earlier paper (1) , magnesium, calcium, uric acid, and cholesterol were measured annually in each of 18 healthy individuals, to determine the frequency with which individual series appeared to depart from the stationary, strictly homeostatic model. One purpose of the present paper is to extend this analysis to data on 14 biochemical and seven hematological tests in a much larger sample of healthy subjects.
In addition, we shall examine the properties of "forecast ranges" provided by these statistical models, particularly sensitivity of models to a trend in the data.
Materials and Methods
The serial measurements used in this study were obtained from 115 men and 47 women who participated in a community-wide program of biochemical profiling and health surveillance sponsored by the Institute for Health Research, San Francisco.
Ages at the time the first blood samples were collected ranged from 27 to 74 years among men (median, 42), and from 24 to 68 years among women (median, 36). At least four sets of blood samples were collected from each individual: a baseline set of five to 10 weekly samples followed by three update sets, each usually comprising three weekly samples. The interval between sampling periods ranged from nine to 15 months. To equalize the weight attached to each sampling period, we included only the first three weekly observations during each period for this analysis.
All 162 individuals studied met the following conditions:
(a) pursuing their usual activities, (b) having no history of recent illness or chronic disease, (c) not currently undergoing medical treatment for any purpose, The Coulter "4C" was used for cell count control. Specimens were mixed continuously on a blood rocker tray (Coulter) until assayed.
Statistical Analyses and Results
As 
RBC
Hematocrit WBC a Rounded to two significant figures. At least four sampling periods per subject; at least six degrees of freedom for each within-period mean square. Because these are variances (not standard deviations), they are in squared units (see Table 1 for original units). walk type when multiple within-sampling period observations are available. Even after only four sampling periods with three observations per period, a truly random-walk series would be detected 75% of the time (at the p = 0.05 level) when c = 4 or, equivalently, when , the corresponding ratio of standard deviations, is 2.
PracticalApplication of the Two Models: Use of the "Forecast Range"
Because it is not possible to predict whether a particular individual will show homeostatic or random-walk variation (or some intermediate type) in a given constituent, it has been proposed (1) that both models be applied to cumulative laboratory reports of test results. These two models represent extreme cases of a more general "autoregressive" model (1), so using them together produces ranges on both high and low sides of an analyte concentration against which a new observation may he judged. In practice, it is more convenient to calculate upper and lower limits under each model separately. Each such pair of limits defines a "forecast range" under the respective model. More specifically, suppose that, as part of a health monitoring program, (t -1) annual measurements of the analyte have been made while the subject remained in a healthy state. Then, the statistical significance of the next (current) measurement, X1, could be assessed according to whether or not it fell within the range f1 ± 2S1, where f and S are, respectively, the forecasted value at time t and the estimated standard deviation of the forecast under the particular model applied. In the strictly homeostatic model, f1 is the unweighted mean of the first (t -1) observations.
In the random-walk model, f1 is an exponentially weighted average of these ( Under the homeostatic model, the standard deviation s-becomes the standard deviation of these means, equivalent to sb/\/ , where s is the "between-periods" mean square in the analysis of variance based on the first (t -1) 
21, where (S)t-i
is the variance of the differences between the successive means1, f2 and, as defined above,
is the "within-period" mean square in the analysis of variance of results through the first (t -1) sampling periods. Further, (s)t_j// replaces 7ain the computation of S, the standard deviation of the forecasted value.5 Let (Rh)t and (Rr)t denote the forecast ranges f1 ± 2 S1 calculated under the homeostatic and random-walk models, respectively.
Because each subject underwent at least four annual periods of blood collection, we set t = 4 initially, and calculated (Rh)4 and (Rr)4 for each constituent, against which to judge the mean analyte value observed during the fourth sampling period. Before summarizing the results, we present a self-contained example of the calculations for cholesterol in a subject followed through five sampling periods ( Table 4) . The formulas required to calculate the numbers in each column are given at the bottom of the table. For t = 4, the random-walk range (Rr)4 lies entirely within the homeostatic range (Rh)4. As explained below, this result is due to the downward trend in the first three values of The fourth value breaks this trend, and (Rr) is now larger than, and entirely encloses, (Rh)5. Finally, shows a substantial jump, which exceeds the upper limit of (Rh)5 and touches that of (R)5. Thus, I represents a statistically significant deviation from the prior record. This subject has not yet contributed a sixth round of specimens, but, interestingly, her mean concentration of triglycerides also showed a large increase at the fifth visit, tending to reinforce the probability that the increase in mean cholesterol () shown in Table 4 was more than a random deviation. Table 5 gives an overall summary of results. All series included a sufficient number of weekly observations during the first three sampling periods So that the estimate of average within-period variance was based on at least three degrees of freedom-almost always five or six. Over all constituents, When the number of weekly measurements was not the same for all sampling periods, the term n was replaced by n0, where n0 1/(k
, where k is the number of sampling periods; n, the number of measurements in the jth sampling period; N, the total number of measurements = n3, and , the mean number per sampling period = N/k. On of the autocorrelation between observations. Most (82%) of the series studied here contained only four sampling periods. Because both of the statistical models we have applied require at least three sampling periods as a base, these short series permit only one forecast: that for the fourth observation.
However, when one is monitoring health status or the response of outpatients to therapy, four serial mea- 6 However, as the number of sampling periods (t) increases, a nonhomeostatic series will tend to exhibit random jumps, which may obscure a gentle underlying trend. In such a case (Rr)t would not necessarily be less than (Rt). Mathematically, as t increases (Rr)t will be less than (Rh)t only when the following condition holds: F2 (V1 -1) <1, given FV1 2. Therefore, in a nonstationary series reflecting a large F-ratio (between/within sampling-period variances), V1 must be quite small (<1 or only slightly >1) for (Rr)t to be less than (Rh)t. In other words, in a nonstationary series of moderate length (t 10), (R,) will tend to exceed (Rh)t unless there exists an underlying trend strong enough to overcome the random jumps in the series. This does not mean that if the trend appears only in the last few observations of a random-walk series, it will go undetected, but only that in such a case the homeostatic model may produce narrower ranges more likely to detect the trend. surements may take months or even years to acquire, and therefore are not considered too few to examine for trend or nonrandom deviations. Consequently, we believe it worthwhile to estimate from our results the sensitivity of these forecasting procedures to (a) the presence of trends (linear or curving) during the first four sampling periods, and (b) the occurrence of a relatively large deviation from the earlier record at the fourth sampling time.
Detection of a trend by the fourth serial sample:
We define a trend as existing during the first four sampling periods when two conditions hold: (a) the mean values at these times form a uniformly descending or ascending order (i1 > X > x3 > x4, or <X2 <x3 <x4), and (b) V3 is less than 1. We used V3 <1, involving the first three sampling periods only, instead of V4 <1 because the forecast ranges (Rr)4 and (Rh)4 used to detect a trend by the fourth sampling period are based on results during the preceding three sampling periods. These conditions are not too stringent because they may both hold, even for a fairly gentle but uniform trend. Nevertheless, only 196 series (7.8%) of the 2528 series over all constituents satisfied these conditions.7
In 56% of these series (109/196), the value of 74 fell outside at least the narrower of the two ranges determined from the forecasting models. This was almost always (R)4, the range given by the random-walk model. Observed sensitivity to trend varied from 25 to 35% for total leukocyte count and serum calcium to 70 to 80% for serum alkaline phosphatase, lactate dehydrogenase, and uric acid in serum and mean corpuscular hemoglobin.
However, given the small number of series for each constituent, this degree of variation is not statistically significant; that is, this much would be expected purely from variability in sampling, even if the average sensitivity of 56% were true for each constituent.
This average sensitivity to trend after four sampling periods seems low. On the other hand, many of the trends were nonlinear. To obtain a clearer picture of the situation, we computed for each of these 196 series the ratio of the average numerical change per time period to the average within-sampling-period standard error for that subject, or, more specifically, the ratio [(74 -. This ratio is simply an estimate of the "slope to noise" ratio characterizing the trend. From a study of the distribution of these ratios, we found that the average sensitivity observed was only slightly less than would have been expected after four sampling periods if all trends had been strictly linear. Further details of this evaluation are given in the Appendix. Table 6 lists, for each analyte, the range of changes observed. In all except six analytes (cholesterol, hematocrit, mean corpuscular volume, total protein, aspartate aminotranferase, and total leukocyte count) the greatest changes fell outside at least one of the two forecasting ranges; for each of these six variables, however, the greatest change fell within its forecast ranges, while lesser changes were often outside the expected ranges. Trends were not detected for various reasons. In some cases, variability within a sampling period produced relatively wide forecast ranges. In other series, the trends were distinctly nonlinear, with the greatest changes occurring between the first and second, or second and third, sampling periods. This, too, contributed to wider ranges when results
In 244 of the 2528 series, the four observed mean values were in uniformly ascending or descending order. This does not necessarily imply that in all, or even most, of these series, the true values of these means were so ordered in time. Even if all the observed results in a series had the same true value, or if, given that they had different true values, the latter were not ordered in time, one would still expect by chance alone that 2/4! or 8.5% of observed series (215/2528) would show such ordering. Nevertheless, one would also expect that those series in which the true values did form a time trend would be found among the series in which the observed values also trended. Thus, sensitivity to trends in the observed values is worth investigating. In almost all cases where 74 did not follow an earlier trend but yet fell outside one or both of the ranges, we found that the value of x4 had swung sharply back in the opposite direction (as in Figure ic , discussed below). Such a result may well be of interest to a clinician following the patient's series. The fact that the forecasting procedure called attention to this anti-trend would then be a mark in its favor rather than a fault. Figure 1 presents some interesting trends recognized or, in one case, missed by these methods.
Each graph includes four successive mean values and the forecast ranges calculated for the fourth mean. Figure la ,b shows two trends in cholesterol. In a, x4 fell outside both ranges, while in the subject in b, 74 fell just within the inner range despite the fact that the change, 1x4-741, was slightly greater than in the other trend. The reason lies ii the average variation within a sampling period, which was more than 30% greater in the subject in b and, therefore, produced wider ranges. Thus, a given change in one subject may not appear unusual in view of that person's past biological variability, whereas the same change, or even a slightly smaller one, in another subject with a history of smaller biological variability can be highly significant statistically. However, a trend in annual observations of the magnitude shown in Figure la would probably have to persist for another five to 10 years before evidence of related pathology would appear.
For this particular subject, a 41-year-old woman, dietary changes and exercise were recommended and followed. Her subsequent results reversed the previous trend, and proceeded downward, averaging 1903, 1867, and 1817 mg/L at the fifth, six, and seventh sampling periods, respectively. in all cases, however, X4 values fell outside the forecast ranges under the random-walk model. In each case, the slope-to-noise ratio, defined above, was high enough so that the probability of exceeding these random-walk limits after four sampling periods was well over 85%. Percentage changes, 100 74 -741 /ii were 20% in the series for glucose, uric acid, and leukocyte count (Figure ld, e, 1) , and 10% in the hemoglobin series (Figure lg) . and often vary more widely over time than do erythrocyte counts or hemoglobin. During the three-year monitoring period, a 47-year-old woman (Figure lf) developed chronic sinusitis and some evidence of cirrhosis of the liver. She was sick for 36 days during the last of these years. Her mean leukocyte count during the next (fifth) sampling period was 5.4 X i09/L, continuing the trend. Small changes in hemoglobin, if persistent in one direction, are always clinically significant because hemoglobin is so well controlled.
We observed that the downward trend in Figure  ig (33-year-old man) was reversed at the next sampling period. Continued decrease for two more years would definitely have brought values so far down as to indicate early anemia.
Nonrandom deviations detected in the four-sample series without trends. The forecasting models used here were not proposed specifically to catch trends but rather to detect the occurrence of a single nonrandom value that might indicate either a new steady state or the beginning of a trend in the patient's status. Let us now consider the 2332 series among the 2528 listed in Table 5 that did not show a trend (as defined above) in the mean results of the first four sampling periods. Table 7 at least one of the two forecast ranges computed for each series. Here, the numerical deviation of 54 from the mean of the three previous sampling periods provides the basis for assessing sensitivity to a nonrandom change. On the average, 63% of these deviations in the highest decile were recognized by the forecasting models. This percentage varied among the different analytes, but the variation was not statistically significant because the average decile contained only 11 or 12 series. The purpose of presenting these relatively large observed deviations is to provide a basis for judging, at least roughly, whether these procedures are too sensitive or not sensitive enough, i.e., whether these maximum or near-maximum deviations are likely to be of clinical significance in an apparently healthy individual.
Results from Subjects with Five or More Sampling Periods
A total of 35 subjects were examined at five or more sampling periods, yielding 437 series in all. In 88 series, 74 fell outside at least one of the two forecast ranges, but in only 22 of these did the next mean value, x5, also lie outside a forecast range. The remaining 66 series usually showed regression to the mean, presumably because physiological processes corrected an aberrant condition.
In several of these series, however, the average value during the fifth sampling period was almost as atypical as that during the fourth period, but fell well within the forecast limits. This reflects the fact that when a result (here, 74) differs significantly from earlier observations but is not omitted from the series, the next forecast range is bound to be wider than preceding ranges and therefore is less apt to exclude another atypical result.
In 15% of these 437 series the forecast range (Rr)5 lay entirely within (Rh)5. This is considerably less than the proportion (23%) of these same series in which (Rr)4 lay within (Rh)4. This finding is in accord with ourexpectations6 that as the number of sampling periods increases, the random jumps characteristic of a nonstationary series would tend to obscure a gentle trend, increasing the likelihood that the forecast range associated with the random-walk model would exceed that derived from the stationary homeostatic model. We have no evidence at this time that any of the trends observed in these data after four or five sampling periods were indicative of early pathology. Thus, our finding ( processes. They suggest that after each new measurement, a "posterior" probability be computed from Bayes' formula for each of a number of selected nonstationary models. The basic model would be the random-walk model used here. An alternative model might be a "linear-growth" model in which a nonzero slope term is added to the random walk. If, after several ohservations, the probability attached to the linear-growth model exceeded some preselected threshold, the existence of a trend would be signaled. A threshold slope for this linear model could be defined so that the corresponding probability would relate to change of a specified magnitude or greater. To start the computations, prior estimates of biological and analytical variances (obtained, for example, from published studies on healthy subjects), would have to be inserted in the programs, but these would gradually be replaced by estimates from the subject's own series. This Bayesian approach appears to have the potential for greater flexibility and power than the significance-testing method of forecast ranges used in this study. However, it will not be nearly as simple and may not be feasible for inclusion in typical computing systems for clinical laboratories.
Discussion
When the required computer programs become available, we hope to explore their use on data from periodic health-monitoring studies.
We are especially grateful to Martha Harnly and James Penton for their invaluable technical assistance during this study.
Appendix. Expected Sensitivity ("Power") of Forecasting Models to Linear Trend after Four Observations from Beginning of Trend
In two recent papers (12, 13) , the power of these forecasting procedures, particularly the random-walk model, to detect a strictly linear trend has been discussed.
It was pointed out that this power depends in part on the "signal-to-noise" ratio of the trend, that is, the ratio of slope to analytical error, or, in the present case, to the within-sampling-period error, which includes both analytical error and short-term biological variation.
As we stated, this ratio after four sampling periods maybe estimated by [(74-74)/3]/no/s. The power of the model also depends (inversely) on the parameter c, estimated here as #{234} = (nos/s) -2. As we noted earlier, when the observations follow a linear trend, #{234} is usually negative and therefore set equal to zero. Let (b/cr)o represent the minimum slope-to-noise ratio required for either the random-walk model with c = 0 or the homeostatic model to detect, with probability p. the presence of a linear trend by the fourth sampling period, by use of a two-sided significance test at the 5% level. Then, by use of the theory outlined dures. The observed value of 63.5 % is evidence, therefore, that in practice these methods are at least as sensitive to linear trends as theory would predict.
In the remaining 40 series, the median value of #{234} was 1.67, and the median estimated slope-to-noise rate 2.42. For these values, the theoretical expected probability of detection of a strictly linear trend by the fourth sampling period is about 70%. However, in only 10 of these series, or 25%, were the trends recognized because of strong nonlinearities in the changes from one sampling period to the next. Thus, overall, the expected probability of detecting these 196 trends by the fourth sampling period, if they had been strictly linear, is about 60%. In fact, 56% of the trends were so detected, despite the existence of nonlinearities.
